SPS
HRMY icon

Susquehanna Portfolio Strategies’s Harmony Biosciences HRMY Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,785
Closed -$2.2M – 1032
2025
Q4 		$2.2M Buy
+58,785
New +$1.93M 0.03% 481
2025
Q3 		– Sell
-9,270
Closed -$293K – 1072
2025
Q2 		$293K Buy
+9,270
New +$298K 0.01% 761
2024
Q1 		– Sell
-15,601
Closed -$504K – 865
2023
Q4 		$504K Buy
+15,601
New +$435K 0.01% 765

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna Portfolio Strategies's HRMY Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 58,785 shares — an estimated $2.2M sold.

Susquehanna Portfolio Strategies first reported a position in HRMY in Q4 2023 and held it in 3 quarters. The position peaked at $2.2M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 58,785 Harmony Biosciences shares in Q1 2026, an estimated $2.2M.
  • Susquehanna Portfolio Strategies first reported a position in Harmony Biosciences in Q4 2023 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's Harmony Biosciences position peaked at $2.2M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.